Wei-Ting Hwang
University of Pennsylvania
H-index: 71
North America-United States
Top articles of Wei-Ting Hwang
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Survival analysis under imperfect record linkage using historic census data | BMC Medical Research Methodology | Arielle K Marks-Anglin Frances K Barg Michelle Ross Douglas J Wiebe Wei-Ting Hwang | 2024/3/13 |
Real-world comparison of low-versus high-dose continuous 5FU infusion in patients receiving triplet chemotherapy plus bevacizumab for newly diagnosed metastatic colorectal … | William Joseph Chapin Wei-Ting Hwang Ronac Mamtani Mark H O'Hara | 2024/1/20 | |
Characteristics of long-term survivors with EGFR mutant (EGFRm) metastatic non-small cell lung cancer (mNSCLC) | Melina Elpi Marmarelis Connor B Grady Caroline McCoach Fangdi Sun Geoffrey Liu | 2023/6/1 | |
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial | Nature Cancer | Stephen J Bagley Zev A Binder Lamia Lamrani Eliana Marinari Arati S Desai | 2024/1/12 |
CAR T-cell immunotherapy in minority patients with lymphoma | NEJM Evidence | Guido Ghilardi Staci Williamson Raymone Pajarillo Luca Paruzzo Linhui Chen | 2024/3/26 |
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer | medRxiv | Connor B Grady Wei-Ting Hwang Joshua E Reuss Wade Iams Amanda Cass | 2024 |
Long-term stability of clinical-grade lentiviral vectors for cell therapy | Molecular Therapy Methods & Clinical Development | Julie K Jadlowsky Rachel Leskowitz Stephen McKenna Jayashree Karar Yujie Ma | 2024/3/14 |
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results | Nature Medicine | Stephen J Bagley Meghan Logun Joseph A Fraietta Xin Wang Arati S Desai | 2024/3/13 |
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient … | Clinical Cancer Research | Stephanie L Wethington Payal D Shah Lainie Martin Janos L Tanyi Nawar Latif | 2023/8/1 |
Real-world comparison of triplet-versus doublet-chemotherapy with bevacizumab in patients with newly diagnosed metastatic colorectal cancer (mCRC). | William Joseph Chapin Wei-Ting Hwang Ronac Mamtani Mark H O'Hara | 2023/6/1 | |
Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium | Blood | Peter A Riedell Connor Grady Loretta J Nastoupil Alejandro Luna Nausheen Ahmed | 2023/11/28 |
P2. 31-05 Determining Lines of Therapy in Patients with Metastatic Non-Small Cell Lung Cancer Using Real-World Data | Journal of Thoracic Oncology | CB Grady L Sun JE Reuss A Cass G Liu | 2023/11/1 |
Phase I study of repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab in patients with newly diagnosed, MGMT-unmethylated glioblastoma | Stephen J Bagley Zev A Binder Arati S Desai Maclean P Nasrallah Eileen Maloney | 2023/3/28 | |
Association between availability of molecular genotyping results and overall survival in patients with advanced nonsquamous non–small-cell lung cancer | JCO precision oncology | Charu Aggarwal Melina E Marmarelis Wei-Ting Hwang Dylan G Scholes Tara L McWilliams | 2023/7 |
Sequential T-Cell Engagement for Myeloma (“STEM”) Trial: A Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy | Blood | Adam D Cohen Wei-Ting Hwang Sandra Susanibar-Adaniya Dan T Vogl Alfred L Garfall | 2023/11/28 |
CTIM-40. EARLY RADIOGRAPHIC RESPONSE AND ENGRAFTMENT OF PHASE I FIRST-IN-HUMAN BICISTRONIC CAR T CELLS CORRELATE WITH REAL-TIME AUTOLOGOUS GBM ORGANOID CYTOLYSIS | Neuro-Oncology | Meghan Logun Stephen J Bagley Xin Wang Daniel Zhang Yusha Sun | 2023/11/1 |
Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy | Blood Cancer Discovery | Alfred L Garfall Adam D Cohen Sandra P Susanibar-Adaniya Wei-Ting Hwang Dan T Vogl | 2023/3/1 |
Association of multi-criteria derived air toxics hazard score with lung cancer incidence in a major metropolitan area | Frontiers in Public Health | Angela Y Zhu Tara L McWilliams Thomas P McKeon Anil Vachani Trevor M Penning | 2023/6/26 |
MA14. 04 Prospective Trial of an EMR-based Nudge to Increase Molecular Genotyping in Newly Diagnosed Metastatic Non-squamous NSCLC | Journal of Thoracic Oncology | ME Marmarelis DG Scholes TL McWilliams W-T Hwang JA Kosteva | 2023/11/1 |
A Phase 2, Single-Arm, Non-Inferiority Study of Limited-Duration Teclistamab for Relapsed and Refractory Multiple Myeloma (LimiTec) | Blood | Beatrice Razzo Connor Grady Sandra Susanibar-Adaniya Adam Waxman Dan T Vogl | 2023/11/28 |
Co-Authors
